Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
positive crawled date : 2020 - 12 - 09 save search
Redfin to Present at Piper Sandler P.S. It's Friday Series: The Future of Home & Housing
Published: 2020-12-09 (Crawled : 23:12) - prnewswire.com
RDFN 4 | $5.37 2.48% 2.33% 3.9M
|
Finance
|
| O: -0.41%
H: 5.76%
C: 5.16%
positive xipere
Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date November 30, 2020
Published: 2020-12-09 (Crawled : 21:06) - globenewswire.com
NDAQ | $61.09 -0.18% -0.17% 1.9M
|
Finance
|
| O: -0.28%
H: 0.49%
C: -0.6%
positive nasdaq
Top-line Final Data from Cantrixil Phase I Study Confirms Prior Positive Efficacy and Safety Signals
Published: 2020-12-09 (Crawled : 20:01) - biospace.com/
KZIA | $0.395 4.78% -2.45% 130K
|
Health Technology
|
| O: 1.58%
H: 4.66%
C: -3.59%
positive topline
RxPONDER Study Results Demonstrate that the Oncotype DX® Test Can Now Spare Chemotherapy Use in the Majority of Women with Node-positive Early-stage Breast Cancer
Published: 2020-12-09 (Crawled : 20:00) - biospace.com/
EXAS | $63.53 1.8% 1.79% 1.3M
|
Health Technology
|
| O: 0.56%
H: 0.16%
C: -2.94%
breast cancer cancer test positive therapy results
Xenetic Biosciences, Inc. Announces Positive Data from Partner’s Pivotal Phase 3 Clinical Trial Utilizing PolyXen(R) Platform Technology
Published: 2020-12-09 (Crawled : 17:00) - biospace.com/
XBIO | $3.85 2.39% 7.32% 2.7K
|
Health Technology
|
| O: 258.33%
H: 51.16%
C: -18.09%
positive phase 3 trial
INOVIO's VGX-3100 Demonstrates Positive Phase 2 Efficacy In Treatment of Precancerous Anal Dysplasia Caused by HPV-16/18
Published: 2020-12-09 (Crawled : 16:00) - biospace.com/
INO | $10.37 3.49% 3.09% 240K
|
Health Technology
|
| O: 0.08%
H: 0.67%
C: -4.43%
positive cancer treatment phase 2
Evelo Biosciences Reports Positive Topline Clinical Data in Phase 1b Trial of EDP1815 in Atopic Dermatitis
Published: 2020-12-09 (Crawled : 12:04) - globenewswire.com
EVLO | $0.3165 -87.39% 710K
|
Health Technology
|
| O: 7.06%
H: 35.6%
C: 14.26%
positive dermatitis trial topline atopic dermatitis phase 1b phase 2b bioscience
Gainers vs Losers
| 77% | 23% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 26M
|
AGBA | $2.97 137.6% 57.48% 66M
|
Finance
EDBL | News | $6.59 75.27% 41.8% 2M
|
ZAPP | $4.44 50.2% 33.12% 370K
|
n/a
MTC | $2.24 43.59% 30.67% 6M
|
Technology Services
OPRT | News | $3.15 40.0% 29.13% 12M
|
Finance
SHIM | $3.045 35.33% 26.23% 870K
|
HKIT | $1.33 30.39% 24.16% 390K
|
Technology Services
ABVC | $1.35 29.81% 23.53% 7.1M
|
Wholesale Trade
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.